Clinical Trial Details


Research Study Summary

Scleroderma and Pulmonary Hypertension (PHT) - Adults


People with scleroderma and early PHT are asked to participate in a research study being conducted by North Shore-LIJ Health System.

You may be eligible to participate in this study if you:

  • Are at least 18 years of age
  • Have been diagnosis with scleroderma and pulmonary hypertension

You may not participate in this study if you:

  • Have been previously diagnosed with PHT and treated for more than 6 months
  • Have severe interstitial lung disease (a variety of diseases involving the lung tissue),
  • Pulmonary thrombotic disease (blood clots in the lung),
  • Heart failure (heart loses its ability to efficiently pump blood throughout the body),
  • Cardiomyopathy (disease of the heart muscle),
  • History of coronary artery disease(A narrowing or blockage of the coronary arteries) or
  • Other cardio-pulmonary problems (Relating to the heart and lungs.)
To Learn more

CW ID: 120729
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Michelle Kong, Study Coordinator
Biomedical Research Alliance of New York
NS-LIJ Health Systems
Division of Rheumatology & Allergy-Clinical Immunology
2800 Marcus Ave, Suite 200
Lake Success, NY 11042
Phone: 516-708-2557
Fax: 516-708-2574

View Map

Research Center Information:

Biomedical Research Alliance of New York

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.